Mudit K.  Jain net worth and biography

Mudit Jain Biography and Net Worth

Director of CVRx
Mudit is a Founding General Partner of Treo Ventures, and the CEO and co-founder of NuXcel, a medical device accelerator. Mudit also co-founded and serves as Chairman of the Board of ShiraTronics, Inc., a NuXcel spin off company.

Mudit has over two decades of medical device industry experience across company formation, R&D, and business development. In addition to his private venture capital experiences at Treo Ventures, and Synergy Life Science Partners, Mudit also brings a strategic investment perspective based on his tenure at Johnson and Johnson Development Corporation.

Mudit has served on the boards of several medical device companies, from early to commercial growth stage, resulting in successful IPOs and M&A transactions. Mudit current serves on the boards of Inspire Medical Systems (NYSE: INSP), Neochord, Inc., ShiraTronics, Inc., CVRx, Inc., and Noctrix, Inc. Some of his prior investments/board responsibilities include Irhythm Technologies (NSDQ:IRTC), Aptus Endosystems (Acqd. by Medtronic), CardioMEMS (Acqd. by St. Jude Medical), Impres Medical (Acqd. by J&J), and Neuspera,Inc. Mudit also serves on the Board of Visitors of the Graduate School at Duke University, External Advisory Board of John Hopkins University Center for Bioengineering Innovation and Design.

Prior to his investing career, Mudit held operational roles in the Cardiac Rhythm Management Division of Guidant Corporation, and played a key role in developing novel device technologies for heart failure, remote cardiac monitoring, and cardiac ablation. Mudit holds 8 issued patents and has authored several peer reviewed publications.

Mudit graduated with a B.E. in Electrical Engineering from REC, Nagpur, India, where he was a gold medal recipient for academic achievements. He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.

What is Mudit K. Jain's net worth?

The estimated net worth of Mudit K. Jain is at least $29,542.50 as of August 12th, 2021. Mr. Jain owns 1,625 shares of CVRx stock worth more than $29,543 as of March 28th. This net worth evaluation does not reflect any other investments that Mr. Jain may own. Learn More about Mudit K. Jain's net worth.

How do I contact Mudit K. Jain?

The corporate mailing address for Mr. Jain and other CVRx executives is , , . CVRx can also be reached via phone at 763-416-2840 and via email at [email protected]. Learn More on Mudit K. Jain's contact information.

Has Mudit K. Jain been buying or selling shares of CVRx?

Mudit K. Jain has not been actively trading shares of CVRx during the last ninety days. Most recently, on Thursday, November 18th, Mudit K. Jain bought 875 shares of CVRx stock. The stock was acquired at an average cost of $14.63 per share, with a total value of $12,801.25. Learn More on Mudit K. Jain's trading history.

Who are CVRx's active insiders?

CVRx's insider roster includes Mudit Jain (Director), and Kirk Nielsen (Director). Learn More on CVRx's active insiders.

Are insiders buying or selling shares of CVRx?

During the last twelve months, insiders at the sold shares 4 times. They sold a total of 8,020 shares worth more than $183,176.38. The most recent insider tranaction occured on February, 20th when insider Paul Verrastro sold 2,545 shares worth more than $55,760.95. Insiders at CVRx own 18.3% of the company. Learn More about insider trades at CVRx.

Information on this page was last updated on 2/20/2024.

Mudit K. Jain Insider Trading History at CVRx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2021Buy875$14.63$12,801.25View SEC Filing Icon  
8/12/2021Buy625$19.72$12,325.001,625View SEC Filing Icon  
See Full Table

Mudit K. Jain Buying and Selling Activity at CVRx

This chart shows Mudit K Jain's buying and selling at CVRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CVRx Company Overview

CVRx logo
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Read More

Today's Range

Now: $18.18
Low: $18.08
High: $18.60

50 Day Range

MA: $22.69
Low: $17.99
High: $29.20

2 Week Range

Now: $18.18
Low: $8.38
High: $33.13

Volume

52,832 shs

Average Volume

151,476 shs

Market Capitalization

$380.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33